Cladis Investment Advisory, LLC Gilead Sciences, Inc. Transaction History

Cladis Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $202,020 - $227,535	-3,500 Closed	0 $0
Q1 2022 Oct 08, 2024	SELL	$57.92 - $72.58 $69,504 - $87,096	-1,200 Reduced 21.05%	4,500 $268 Million
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $69,504 - $87,096	-1,200 Reduced 25.53%	3,500 $208,000
Q4 2021 Oct 08, 2024	BUY	$64.88 - $73.64 $369,816 - $419,748	5,700 New	5,700 $414 Million
Q4 2021 Oct 01, 2024	BUY	$64.88 - $73.64 $304,936 - $346,108	4,700 New	4,700 $341 Million
Q4 2021 May 10, 2022	BUY	$64.88 - $73.64 $304,936 - $346,108	4,700 New	4,700 $341,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Cladis Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Cladis Investment Advisory, LLC with notifications on news.